You can buy or sell SBBP and other stocks, options, ETFs, and crypto commission-free!
Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. Read More The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA. The listed name for SBBP is Strongbridge Biopharma plc Ordinary Shares.
Lower Southampton, Pennsylvania
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market